Literature DB >> 18614025

Cerebral and peripheral amyloid phagocytes--an old liaison with a new twist.

Mathias Jucker1, Frank L Heppner.   

Abstract

In this month's issue of Nature Medicine, Town et al. suggest that peripheral macrophages invading the brain reduce cerebral amyloidosis and thus may play a key role in the pathogenesis of Alzheimer's disease (AD). This observation intensifies the longstanding controversy of whether mononuclear cells such as macrophages and/or microglial cells are beneficial or detrimental in AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614025      PMCID: PMC2676343          DOI: 10.1016/j.neuron.2008.06.014

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  15 in total

1.  Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment.

Authors:  J Priller; A Flügel; T Wehner; M Boentert; C A Haas; M Prinz; F Fernández-Klett; K Prass; I Bechmann; B A de Boer; M Frotscher; G W Kreutzberg; D A Persons; U Dirnagl
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

2.  Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.

Authors:  F Bard; C Cannon; R Barbour; R L Burke; D Games; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; I Lieberburg; R Motter; M Nguyen; F Soriano; N Vasquez; K Weiss; B Welch; P Seubert; D Schenk; T Yednock
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

3.  Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils.

Authors:  J Frackowiak; H M Wisniewski; J Wegiel; G S Merz; K Iqbal; K C Wang
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Phagocytosis of beta/A4 amyloid fibrils of the neuritic neocortical plaques.

Authors:  H M Wisniewski; M Barcikowska; E Kida
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  Mature monocytic cells enter tissues and engraft.

Authors:  D W Kennedy; J L Abkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 6.  Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

Authors:  Tony Wyss-Coray
Journal:  Nat Med       Date:  2006-09       Impact factor: 53.440

7.  Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice.

Authors:  Anna K Stalder; Florian Ermini; Luca Bondolfi; Werner Krenger; Guido J Burbach; Thomas Deller; Janaky Coomaraswamy; Matthias Staufenbiel; Regine Landmann; Mathias Jucker
Journal:  J Neurosci       Date:  2005-11-30       Impact factor: 6.167

8.  Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein.

Authors:  Muriel Asheuer; Françoise Pflumio; Sonia Benhamida; Anne Dubart-Kupperschmitt; Françoise Fouquet; Yoshinori Imai; Patrick Aubourg; Nathalie Cartier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

9.  Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology.

Authors:  Terrence Town; Yasmina Laouar; Christopher Pittenger; Takashi Mori; Christine A Szekely; Jun Tan; Ronald S Duman; Richard A Flavell
Journal:  Nat Med       Date:  2008-06-01       Impact factor: 53.440

10.  Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.

Authors:  Alain R Simard; Denis Soulet; Genevieve Gowing; Jean-Pierre Julien; Serge Rivest
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

View more
  19 in total

Review 1.  Murine models of Alzheimer's disease and their use in developing immunotherapies.

Authors:  Thomas Wisniewski; Einar M Sigurdsson
Journal:  Biochim Biophys Acta       Date:  2010-05-13

Review 2.  The multifaceted profile of activated microglia.

Authors:  Marina A Lynch
Journal:  Mol Neurobiol       Date:  2009-07-23       Impact factor: 5.590

3.  Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy.

Authors:  Allan Wang; Pritam Das; Robert C Switzer; Todd E Golde; Joanna L Jankowsky
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

Review 4.  Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.

Authors:  Thomas Wisniewski; Allal Boutajangout
Journal:  Brain Struct Funct       Date:  2009-12-10       Impact factor: 3.270

5.  Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease.

Authors:  Magali Dumont; Elizabeth Wille; Noel Y Calingasan; Davide Tampellini; Charlotte Williams; Gunnar K Gouras; Karen Liby; Michael Sporn; Carl Nathan; M Flint Beal; Michael T Lin
Journal:  J Neurochem       Date:  2009-02-07       Impact factor: 5.372

6.  Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia.

Authors:  Stefan A Grathwohl; Roland E Kälin; Tristan Bolmont; Stefan Prokop; Georg Winkelmann; Stephan A Kaeser; Jörg Odenthal; Rebecca Radde; Therese Eldh; Sam Gandy; Adriano Aguzzi; Matthias Staufenbiel; Paul M Mathews; Hartwig Wolburg; Frank L Heppner; Mathias Jucker
Journal:  Nat Neurosci       Date:  2009-10-18       Impact factor: 24.884

Review 7.  CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease?

Authors:  Kavon Rezai-Zadeh; David Gate; Terrence Town
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-11       Impact factor: 4.147

Review 8.  Macrophages in Alzheimer's disease: the blood-borne identity.

Authors:  David Gate; Kavon Rezai-Zadeh; Dominique Jodry; Altan Rentsendorj; Terrence Town
Journal:  J Neural Transm (Vienna)       Date:  2010-06-02       Impact factor: 3.575

Review 9.  AD vaccines: conclusions and future directions.

Authors:  Thomas Wisniewski
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-04       Impact factor: 4.388

Review 10.  Alternative Abeta immunotherapy approaches for Alzheimer's disease.

Authors:  Terrence Town
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-04       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.